Skip to main content

Table 1 Characteristics of 128 Non-small Cell Lung Cancer Patients, RPCI, 1995–1999

From: Prognostic significance of MCM2, Ki-67 and gelsolin in non-small cell lung cancer

Characteristics

N = 128 (%)

Sex

 

   Male

70 (54.7%)

   Female

58 (45.3%)

Race

 

   Caucasians

120 (93.8%)

   Non-Caucasians

8 (6.2%)

Age

 

   Mean (SD)

64.2 (10.7)

Smoking status

 

   Never

11 (8.6%)

   Former

64 (50.0%)

   Current

53 (41.4%)

Pack-years of smoking (a)

 

   Mean (SD)

51.4 (27.0)

Family history of lung cancer

 

   No

87 (68.0%)

   Yes

41 (32.0%)

Zubrod Performance status

 

   Without symptom

87 (68.0%)

   With symptom

41 (32.0%)

Weight loss (b)

 

   No

110 (85.9%)

   Yes

18 (14.1%)

Vital status

 

   Alive

49 (38.3%)

   Dead

79 (61.7%)

Pathologic TNM stage

 

   I

75 (58.6%)

   II

31 (24.2%)

   IIIA

22 (17.2%)

Histology

 

   Adenocarcinoma

77 (60.2%)

   Squamous

39 (30.5%)

   Large cell

5 (3.9%)

   Others

7 (5.5%)

Grade

 

   Well differentiation

3 (2.3%)

   Moderate differentiation

48 (37.5%)

   Poor differentiation

77 (60.2%)

Receiving adjuvant chemotherapy

 

   No

109 (85.2%)

   Yes

19 (14.8%)

MCM2

 

   Low

49 (38.3%)

   High

79 (61.7%)

Ki-67

 

   Low

28 (21.9%)

   High

100 (78.1%)

Gelsolin level

 

   Low

86 (67.2%)

   High

42 (32.8%)

  1. (a). Pack-years of smoking: packs of cigarette smoked per day multiplied by years of smoking;
  2. (b). Weight loss: ≥ 5% of total weight loss within 3 months prior to diagnosis.